Faslodex
Payments companies reported to CMS as associated with Faslodex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Faslodex, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Faslodex
These are the largest totals companies reported as associated with Faslodex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Anna Akopyan | Glendale, CA | Adult Health (Nurse Practitioner) | $224.97 |
| Aatirah Holmes | Alexandria, VA | Pediatrics | $118.77 |
| Marshall Stagg | Baton Rouge, LA | Hematology & Oncology | $99.00 |
| Hillary Davis | Jonesboro, AR | Family | $99.00 |
| Alhareth Alsayed | Sterling, IL | Medical Oncology | $84.95 |
| Yeo Jin Moon | Seattle, WA | Family | $84.76 |
| Ben Chue | Seattle, WA | Hematology & Oncology | $84.76 |
| Debra Del Valle | San Antonio, TX | Family | $74.99 |
| Shehzad Aziz | Salinas, CA | Hematology & Oncology | $74.99 |
| Twinkle Patel | North Chicago, IL | Physician Assistant | $74.99 |
Prescribed Faslodex?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.